Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

NCT00024284 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: carboplatin
DRUG: irinotecan hydrochloride

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]